Advertisement

Reactions Weekly

, Volume 1730, Issue 1, pp 160–160 | Cite as

Ibrutinib

Bleeding disorders: case report
Case report
  • 10 Downloads

Reference

  1. Mock J, et al. Risk of Major Bleeding with Ibrutinib. Clinical Lymphoma, Myeloma & Leukemia 18: 755-761, No. 11, Nov 2018. Available from: URL: http://doi.org/10.1016/j.clml.2018.07.287 - USACrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations